Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2007

The effect of paraoxon on GABA uptake in rat cerebellar synaptosomes

Amene Shahroukhi, Asghar Ghasemi, Fereshte Poorabdolhossein, Alireza Asgari, Ali Khoshbaten

Med Sci Monit 2007; 13(9): BR194-199 :: ID: 498375

Abstract

Background: The compounds used to treat organophosphate (OP) poisoning are not able to fully alleviate long-lasting effects. They are mainly used to antagonize the cholinergic effects of OPs; however, non-cholinergic effects such as interference with different neurotransmitter systems, especially GABA release and uptake, are now attracting more attention.
Material/Methods: Cerebellar synaptosomes were used to investigate any potential interaction between paraoxon and GABA uptake. The cerebella of 250- to 280-g Wistar rats were rapidly dissected out, homogenized, centrifuged, and incubated with 0.004 µM [[sup]3[/sup]H]GABA in the presence of different doses of paraoxon for 15 minutes at 37°C. At the end of the incubation period, the synaptosomes were layered in chambers of a superfusion system (UGO). To assay the amount of [[sup]3[/sup]H]GABA uptake, radioactivity was measured using a β-counter (Winspectrul).
Results: Mean GABA uptake was 111, 95, 71, 73, and 75 percent of the control values in the presence of paraoxon concentrations of 0.01, 0.1, 1, 10, and 100 µM, respectively. Accordingly, GABA uptake was significantly reduced at doses 1, 10, and 100 µM of paraoxon (P<0.05).
Conclusions: Paraoxon may interfere with GABA uptake by cerebellar synaptosomes at micromolar concentrations or higher.

Keywords: Cholinesterases - metabolism, Brain - ultrastructure, Hydro-Lyases - metabolism, Microscopy, Electron, Paraoxon - pharmacology, Rats, Wistar, Synaptosomes - ultrastructure, gamma-Aminobutyric Acid - pharmacology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750